Top Markets
Coin of the day
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc.

4186
株式のランク #29148
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a... Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
株価
$0.2518483
時価総額
$22.67M
変化(1日)
-1.61%
変化(1年)
-31.34%
TW
取引 Taiwan Advance Bio-Pharmaceutical Inc. (4186)

カテゴリー

Taiwan Advance Bio-Pharmaceutical Inc.(4186)の収益
Aug 2026 時点の収益 TTM: 0
Taiwan Advance Bio-Pharmaceutical Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Taiwan Advance Bio-Pharmaceutical Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$12.62B -
US
$6.02B -
NL
$2.23B -
US
$15.70B -
AU
- -
CH